Spotlight on apoptosisBLAGOSKLONNY, M. V.Leukemia. 2000, Vol 14, Num 8, pp 1500-1501, issn 0887-6924Article

STI-571 must select for drug-resistant cells but 'no cell breathes fire out of its nostrils like a dragon'BLAGOSKLONNY, M. V.Leukemia. 2002, Vol 16, Num 4, pp 570-572, issn 0887-6924Article

Unwinding the loop of Bcl-2 phosphorylationBLAGOSKLONNY, M. V.Leukemia. 2001, Vol 15, Num 6, pp 869-874, issn 0887-6924Article

Tissue-selective therapy of cancerBLAGOSKLONNY, M. V.British journal of cancer. 2003, Vol 89, Num 7, pp 1147-1151, issn 0007-0920, 5 p.Article

Treatment with inhibitors of caspases, that are substrates of drug transporters, selectively permits chemotherapy-induced apoptosis in multidrug-resistant cells but protects normal cellsBLAGOSKLONNY, M. V.Leukemia. 2001, Vol 15, Num 6, pp 936-941, issn 0887-6924Article

Hsp-90-associated oncoproteins: multiple targets of geldanamycin and its analogsBLAGOSKLONNY, M. V.Leukemia. 2002, Vol 16, Num 4, pp 455-462, issn 0887-6924Article

Cell death beyond apoptosisBLAGOSKLONNY, M. V.Leukemia. 2000, Vol 14, Num 8, pp 1502-1508, issn 0887-6924Article

Drug-resistance enables selective killing of resistant leukemia cells : exploiting of drug resistance instead of reversalBLAGOSKLONNY, M. V.Leukemia. 1999, Vol 13, Num 12, pp 2031-2035, issn 0887-6924Article

Loss of function and p53 protein stabilizationBLAGOSKLONNY, M. V.Oncogene (Basingstoke). 1997, Vol 15, Num 16, pp 1889-1893, issn 0950-9232Article

Molecular effects of paclitaxel : Myths and reality (A critical review)BLAGOSKLONNY, M. V; FOJO, T.International journal of cancer. 1999, Vol 83, Num 2, pp 151-156, issn 0020-7136Article

Acute overexpression of WT P53 facilitates anticancer drug-induced death of cancer and normal cellsBLAGOSKLONNY, M. V; EL-DEIRY, W. S.International journal of cancer. 1998, Vol 75, Num 6, pp 933-940, issn 0020-7136Article

Sensitive and simple bioassay for human tumour necrosis factor-αBLAGOSKLONNY, M. V; NECKERS, L. M.European cytokine network (Montrouge). 1993, Vol 4, Num 4, pp 279-283, issn 1148-5493Article

Cytostatic and cytotoxic activity of sex steroids against human leukemia cell linesBLAGOSKLONNY, M. V; NECKERS, L. M.Cancer letters. 1994, Vol 76, Num 2-3, pp 81-86, issn 0304-3835Article

Carcinogenic metals induce hypoxia-inducible factor-stimulated transcription by reactive oxygen species-independent mechanismSALNIKOW, K; WEICHENG SU; BLAGOSKLONNY, M. V et al.Cancer research (Baltimore). 2000, Vol 60, Num 13, pp 3375-3378, issn 0008-5472Article

Efficacy of microtubule-active drugs followed by ketoconazole in human metastatic prostate cancer cell linesBLAGOSKLONNY, M. V; DIXON, S. C; FIGG, W. D et al.The Journal of urology. 2000, Vol 163, Num 3, pp 1022-1026, issn 0022-5347Article

Defects in p21^WAF1/CIP1, Rb, and c-myc signaling in phorbol Ester-resistant cancer cellsBLAGOSKLONNY, M. V; PRABHU, N. S; EL-DEIRY, W. S et al.Cancer research (Baltimore). 1997, Vol 57, Num 2, pp 320-325, issn 0008-5472Article

Depletion of p185^erbB2, Raf-1 and mutant p53 proteins by geldanamycin derivatives correlates with antiproliferative activityAN, W. G; SCHNUR, R. C; NECKERS, L et al.Cancer chemotherapy and pharmacology. 1997, Vol 40, Num 1, pp 60-64, issn 0344-5704Article

Mitogen-activated protein kinase pathway is dispensable for microtubule-active drug-induced Raf-1/Bcl-2 phosphorylation and apoptosis in leukemia cellsBLAGOSKLONNY, M. V; CHUMAN, Y; BERGAN, R. C et al.Leukemia. 1999, Vol 13, Num 7, pp 1028-1036, issn 0887-6924Article

Growth factor dependence of NIH 3T3 cells transformed by v-myc oncogenePOSPELOVA, T. V; BLAGOSKLONNY, M. V; ZARITSKY, A. YU et al.Citologiâ. 1990, Vol 32, Num 4, pp 358-363, issn 0041-3771, 6 p.Article

Mechanism of G1-like arrest by low concentrations of paclitaxel : next cell cycle p53-dependent arrest with sub G1 DNA content mediated by prolonged mitosisDEMIDENKO, Z. N; KALURUPALLE, S; HANKO, C et al.Oncogene (Basingstoke). 2008, Vol 27, Num 32, pp 4402-4410, issn 0950-9232, 9 p.Article

Loss of cell cycle control allows selective microtubule-active drug-induced Bcl-2 phosphorylation and cytotoxicity in autonomous cancer cellsBLAGOSKLONNY, M. V; BISHOP, P. C; ROBEY, R et al.Cancer research (Baltimore). 2000, Vol 60, Num 13, pp 3425-3428, issn 0008-5472Article

Geldanamycin-stimulated destabilization of mutated p53 is mediated by the proteasome in vivoWHITESELL, L; SUTPHIN, P; AN, W. G et al.Oncogene (Basingstoke). 1997, Vol 14, Num 23, pp 2809-2816, issn 0950-9232Article

Regulation of BRCA1 by protein degradationBLAGOSKLONNY, M. V; AN, W. G; MELILLO, G et al.Oncogene (Basingstoke). 1999, Vol 18, Num 47, pp 6460-6468, issn 0950-9232Article

Raf-1/bcl-2 phosphorylation : A step from microtubule damage to cell deathBLAGOSKLONNY, M. V; GIANNAKAKOU, P; EL-DEIRY, W. S et al.Cancer research (Baltimore). 1997, Vol 57, Num 1, pp 130-135, issn 0008-5472Article

Suppression of cancer cell growth by adenovirus expressing p21^WAF1/CIP1 deficient in PCNA interactionPRABHU, N. S; BLAGOSKLONNY, M. V; ZENG, Y.-X et al.Clinical cancer research. 1996, Vol 2, Num 7, pp 1221-1229, issn 1078-0432Article